HSBC Holdings plc set a €94.00 ($110.59) target price on Merck KGaA (FRA:MRK) in a research note issued to investors on Wednesday, August 9th. The firm currently has a neutral rating on the healthcare company’s stock.
A number of other analysts also recently weighed in on MRK. Deutsche Bank AG set a €106.00 ($124.71) price objective on Merck KGaA and gave the company a neutral rating in a report on Friday, August 4th. Commerzbank Ag set a €109.00 ($128.24) price target on Merck KGaA and gave the stock a neutral rating in a report on Wednesday, August 9th. Nord/LB set a €100.00 ($117.65) price target on Merck KGaA and gave the stock a neutral rating in a report on Thursday, August 3rd. Morgan Stanley set a €103.00 ($121.18) price target on Merck KGaA and gave the stock a neutral rating in a report on Monday, May 22nd. Finally, J P Morgan Chase & Co reiterated a neutral rating on shares of Merck KGaA in a report on Friday, August 4th. Sixteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Merck KGaA has a consensus rating of Hold and a consensus price target of €108.48 ($127.62).
Merck KGaA (MRK) opened at 91.245 on Wednesday. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The company has a market capitalization of €39.67 billion and a price-to-earnings ratio of 23.786. The firm’s 50-day moving average price is €97.65 and its 200 day moving average price is €103.53.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.